Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 1992 Feb 1;281(Pt 3):597–600. doi: 10.1042/bj2810597

Tyrosine phosphorylation is involved in receptor coupling to phospholipase D but not phospholipase C in the human neutrophil.

I J Uings 1, N T Thompson 1, R W Randall 1, G D Spacey 1, R W Bonser 1, A T Hudson 1, L G Garland 1
PMCID: PMC1130730  PMID: 1371383

Abstract

The tyrosine kinase inhibitors ST271, ST638 and erbstatin inhibited phospholipase D (PLD) activity in human neutrophils stimulated by fMet-Leu-Phe, platelet-activating factor and leukotriene B4. These compounds did not inhibit phorbol ester-stimulated PLD, indicating that they do not inhibit PLD per se, but probably act at a site between the receptor and the phospholipase. In contrast, the protein kinase C inhibitor Ro-31-8220 inhibited phorbol 12,13-dibutyrate- but not fMet-Leu-Phe-stimulated PLD activity, arguing against the involvement of protein kinase C in the receptor-mediated activation of PLD. ST271 did not inhibit Ins(1,4,5)P3 generation, but did inhibit protein tyrosine phosphorylation stimulated by fMet-Leu-Phe. The phosphotyrosine phosphatase inhibitor pervanadate increased tyrosine phosphorylation and stimulated PLD. These results suggest that tyrosine kinase activity is involved in receptor coupling to PLD but not to PtdIns(4,5)P2-specific phospholipase C in the human neutrophil.

Full text

PDF
597

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agwu D. E., McPhail L. C., Chabot M. C., Daniel L. W., Wykle R. L., McCall C. E. Choline-linked phosphoglycerides. A source of phosphatidic acid and diglycerides in stimulated neutrophils. J Biol Chem. 1989 Jan 25;264(3):1405–1413. [PubMed] [Google Scholar]
  2. Berkow R. L., Dodson R. W. Tyrosine-specific protein phosphorylation during activation of human neutrophils. Blood. 1990 Jun 15;75(12):2445–2452. [PubMed] [Google Scholar]
  3. Billah M. M., Anthes J. C. The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem J. 1990 Jul 15;269(2):281–291. doi: 10.1042/bj2690281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Billah M. M., Pai J. K., Mullmann T. J., Egan R. W., Siegel M. I. Regulation of phospholipase D in HL-60 granulocytes. Activation by phorbol esters, diglyceride, and calcium ionophore via protein kinase- independent mechanisms. J Biol Chem. 1989 May 25;264(15):9069–9076. [PubMed] [Google Scholar]
  5. Bonser R. W., Thompson N. T., Randall R. W., Garland L. G. Phospholipase D activation is functionally linked to superoxide generation in the human neutrophil. Biochem J. 1989 Dec 1;264(2):617–620. doi: 10.1042/bj2640617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cabot M. C., Welsh C. J., Zhang Z. C., Cao H. T. Evidence for a protein kinase C-directed mechanism in the phorbol diester-induced phospholipase D pathway of diacylglycerol generation from phosphatidylcholine. FEBS Lett. 1989 Mar 13;245(1-2):85–90. doi: 10.1016/0014-5793(89)80197-8. [DOI] [PubMed] [Google Scholar]
  7. Charbonneau H., Tonks N. K., Walsh K. A., Fischer E. H. The leukocyte common antigen (CD45): a putative receptor-linked protein tyrosine phosphatase. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7182–7186. doi: 10.1073/pnas.85.19.7182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fain J. N. Regulation of phosphoinositide-specific phospholipase C. Biochim Biophys Acta. 1990 Jun 12;1053(1):81–88. doi: 10.1016/0167-4889(90)90029-d. [DOI] [PubMed] [Google Scholar]
  9. Fantus I. G., Kadota S., Deragon G., Foster B., Posner B. I. Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry. 1989 Oct 31;28(22):8864–8871. doi: 10.1021/bi00448a027. [DOI] [PubMed] [Google Scholar]
  10. Gelas P., Ribbes G., Record M., Terce F., Chap H. Differential activation by fMet-Leu-Phe and phorbol ester of a plasma membrane phosphatidylcholine-specific phospholipase D in human neutrophil. FEBS Lett. 1989 Jul 17;251(1-2):213–218. doi: 10.1016/0014-5793(89)81457-7. [DOI] [PubMed] [Google Scholar]
  11. Gettins P., Metzler M., Coleman J. E. Alkaline phosphatase. 31P NMR probes of the mechanism. J Biol Chem. 1985 Mar 10;260(5):2875–2883. [PubMed] [Google Scholar]
  12. Gomez-Cambronero J., Huang C. K., Bonak V. A., Wang E., Casnellie J. E., Shiraishi T., Sha'afi R. I. Tyrosine phosphorylation in human neutrophil. Biochem Biophys Res Commun. 1989 Aug 15;162(3):1478–1485. doi: 10.1016/0006-291x(89)90841-3. [DOI] [PubMed] [Google Scholar]
  13. Gomez-Cambronero J., Wang E., Johnson G., Huang C. K., Sha'afi R. I. Platelet-activating factor induces tyrosine phosphorylation in human neutrophils. J Biol Chem. 1991 Apr 5;266(10):6240–6245. [PubMed] [Google Scholar]
  14. Grinstein S., Furuya W., Lu D. J., Mills G. B. Vanadate stimulates oxygen consumption and tyrosine phosphorylation in electropermeabilized human neutrophils. J Biol Chem. 1990 Jan 5;265(1):318–327. [PubMed] [Google Scholar]
  15. Klausner R. D., Samelson L. E. T cell antigen receptor activation pathways: the tyrosine kinase connection. Cell. 1991 Mar 8;64(5):875–878. doi: 10.1016/0092-8674(91)90310-u. [DOI] [PubMed] [Google Scholar]
  16. Lacal P., Pulido R., Sánchez-Madrid F., Mollinedo F. Intracellular location of T200 and Mo1 glycoproteins in human neutrophils. J Biol Chem. 1988 Jul 15;263(20):9946–9951. [PubMed] [Google Scholar]
  17. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  18. Naccache P. H., Gilbert C., Caon A. C., Gaudry M., Huang C. K., Bonak V. A., Umezawa K., McColl S. R. Selective inhibition of human neutrophil functional responsiveness by erbstatin, an inhibitor of tyrosine protein kinase. Blood. 1990 Nov 15;76(10):2098–2104. [PubMed] [Google Scholar]
  19. Nasmith P. E., Mills G. B., Grinstein S. Guanine nucleotides induce tyrosine phosphorylation and activation of the respiratory burst in neutrophils. Biochem J. 1989 Feb 1;257(3):893–897. doi: 10.1042/bj2570893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Randall R. W., Bonser R. W., Thompson N. T., Garland L. G. A novel and sensitive assay for phospholipase D in intact cells. FEBS Lett. 1990 May 7;264(1):87–90. doi: 10.1016/0014-5793(90)80772-b. [DOI] [PubMed] [Google Scholar]
  21. Shiraishi T., Domoto T., Imai N., Shimada Y., Watanabe K. Specific inhibitors of tyrosine-specific protein kinase, synthetic 4-hydroxycinnamamide derivatives. Biochem Biophys Res Commun. 1987 Aug 31;147(1):322–328. doi: 10.1016/s0006-291x(87)80124-9. [DOI] [PubMed] [Google Scholar]
  22. Shiraishi T., Owada M. K., Tatsuka M., Yamashita T., Watanabe K., Kakunaga T. Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro. Cancer Res. 1989 May 1;49(9):2374–2378. [PubMed] [Google Scholar]
  23. Tateson J. E., Randall R. W., Reynolds C. H., Jackson W. P., Bhattacherjee P., Salmon J. A., Garland L. G. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. Br J Pharmacol. 1988 Jun;94(2):528–539. doi: 10.1111/j.1476-5381.1988.tb11557.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Thomas K. M., Pyun H. Y., Navarro J. Molecular cloning of the fMet-Leu-Phe receptor from neutrophils. J Biol Chem. 1990 Nov 25;265(33):20061–20064. [PubMed] [Google Scholar]
  25. Thompson N. T., Bonser R. W., Garland L. G. Receptor-coupled phospholipase D and its inhibition. Trends Pharmacol Sci. 1991 Nov;12(11):404–408. doi: 10.1016/0165-6147(91)90617-2. [DOI] [PubMed] [Google Scholar]
  26. Thompson N. T., Bonser R. W., Tateson J. E., Spacey G. D., Randall R. W., Hodson H. F., Garland L. G. A quantitative investigation into the dependence of Ca2+ mobilisation on changes in inositol 1,4,5-trisphosphate levels in the stimulated neutrophil. Br J Pharmacol. 1991 Jun;103(2):1592–1596. doi: 10.1111/j.1476-5381.1991.tb09832.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Thompson N. T., Tateson J. E., Randall R. W., Spacey G. D., Bonser R. W., Garland L. G. The temporal relationship between phospholipase activation, diradylglycerol formation and superoxide production in the human neutrophil. Biochem J. 1990 Oct 1;271(1):209–213. doi: 10.1042/bj2710209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Umezawa H., Imoto M., Sawa T., Isshiki K., Matsuda N., Uchida T., Iinuma H., Hamada M., Takeuchi T. Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3. J Antibiot (Tokyo) 1986 Jan;39(1):170–173. doi: 10.7164/antibiotics.39.170. [DOI] [PubMed] [Google Scholar]
  29. Ziegler S. F., Marth J. D., Lewis D. B., Perlmutter R. M. Novel protein-tyrosine kinase gene (hck) preferentially expressed in cells of hematopoietic origin. Mol Cell Biol. 1987 Jun;7(6):2276–2285. doi: 10.1128/mcb.7.6.2276. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES